Citation Impact
Citing Papers
Implications of time‐series gene expression profiles of replicative senescence
2013
Cooperative Interactions of p53 Mutation, Telomere Dysfunction, and Chronic Liver Damage in Hepatocellular Carcinoma Progression
2006
Redox mechanisms in hepatic chronic wound healing and fibrogenesis
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Genetic determinants of hepatic steatosis in man
2011
The DNA-damage response in human biology and disease
2009 StandoutNature
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Hepatocellular carcinoma
2003 Standout
Mammalian Telomeres End in a Large Duplex Loop
1999 Standout
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
2005 StandoutNobel
Molecular pathogenesis of human hepatocellular carcinoma
2002
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
2007 StandoutNobel
Telomere dysfunction in ageing and age-related diseases
2022
Cancer Metastasis: Building a Framework
2006 Standout
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Cellular Senescence in Cancer and Aging
2007 Standout
Endoplasmic Reticulum Stress and the Unfolded Protein Response
2009
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Hepatocellular carcinoma
2012 Standout
Telomere states and cell fates
2000 StandoutNatureNobel
Telomeres and telomerase in cancer
2009
Telomere maintenance and disease
2003
Porphyrias
2010 Standout
Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors
2005 Standout
Telomere Dysfunction Increases Mutation Rate and Genomic Instability
2001 StandoutNobel
Telomerase and ATM/Tel1p Protect Telomeres from Nonhomologous End Joining
2003 StandoutNobel
Telomere dysfunction and the initiation of genome instability
2003 StandoutNobel
The roles of telomeres and telomerase in cell life span
1996
Short Telomeres Limit Tumor Progression In Vivo by Inducing Senescence
2007 StandoutNobel
Cancer genes and the pathways they control
2004 Standout
Short Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity
2005 StandoutNobel
How stem cells age and why this makes us grow old
2007
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation
2005 StandoutNobel
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
1999 StandoutNobel
Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells
2003
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
2008 Standout
Genome maintenance mechanisms for preventing cancer
2001 StandoutNature
Historical claims and current interpretations of replicative aging
2002
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk
2003 Standout
p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
1999 StandoutNobel
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
2003
Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse
1999 StandoutNobel
Senescence and immortalization: role of telomeres and telomerase
2004
The Hallmarks of Aging
2013 Standout
The age of cancer
2000 Nature
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
2003
Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children
2000
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Causes and Metabolic Consequences of Fatty Liver
2008
Down-regulation of hepcidin in porphyria cutanea tarda
2008
Reversible Near-Infrared Fluorescent Probe Introducing Tellurium to Mimetic Glutathione Peroxidase for Monitoring the Redox Cycles between Peroxynitrite and Glutathione in Vivo
2013 Standout
Oxidative DNA damage: mechanisms, mutation, and disease
2003 Standout
Connecting Chromosomes, Crisis, and Cancer
2002 Science
Catalytic Dehydrogenative Cross-Coupling: Forming Carbon−Carbon Bonds by Oxidizing Two Carbon−Hydrogen Bonds
2011 Standout
Telomere fusions caused by mutating the terminal region of telomeric DNA
2000 StandoutNobel
Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.
2003
Broken Limits to Life Expectancy
2002 StandoutScience
Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
2002
Telomerase activity in precancerous hepatic nodules
1998
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Dauer larva quiescence alters the circuitry of microRNA pathways regulating cell fate progression inC. elegans
2012 StandoutNobel
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
End Resection Initiates Genomic Instability in the Absence of Telomerase
2003 StandoutNobel
Works of Takuya Kitada being referenced
In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease
2001
In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases
2002
Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases
2005
Telomere Shortening in Chronic Liver Diseases
1995
Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study.
2000